Contact Us

U.S. Laboratory Locations

421 Wakara Way
Suite 309
Salt Lake City, UT 84108

New York
101 Avenue of the Americas, Suite 324
New York, NY 10013

Corporate Offices

New York
1460 Broadway
New York, NY 10036

421 Wakara Way
Suite 309
Salt Lake City, UT 84108

Renalytix AI PLC

Registered Office

Avon House
19 Stanwell Road
Cardiff, United Kingdom

Company Secretary: Salim Hamir


Renalytix AI

Media Enquiries
Sara Kienke
Tel: 801-447-2698

Walbrook PR Ltd

Media and Investor Relations
Tel: +44 (0)20 7933 8790

Latest News


KidneyIntelX in Multi-Center Study to Monitor and Predict Kidney Risk in COVID-19 Patients

Surge in Chronic Kidney Disease and Kidney Failure Expected Post-COVID-19 Mount Sinai-Led Study to Assess 4,000 Surviving COVID-19 Patients.. Read More →

Total Voting Rights

As of 31 July 2020, the Company's issued and fully paid share capital consists of 72,029,634 ordinary shares with a nominal value of £0.0025 each,.. Read More →

Over allotment option exercise raises an additional US$10.9m

Renalytix AI plc announces that the underwriters of its global offering of new ordinary shares.. Read More →